Newly released data by Fact.MR on canine separation anxiety treatment industry analysis shows that global market value enjoyed year-on-year (YoY) growth of 5.4% in 2021, with the market valued at US$ 22.45 Mn.
The Fact.MR new report on the market survey of Canine Separation Anxiety Treatment gives estimations of the Size of Canine Separation Anxiety Treatment Market and the overall share of key regional segments
The latest market research report analyzes Canine Separation Anxiety Treatment Market demand by segments. Providing business leaders with insights On Canine Separation Anxiety Treatment Market And how they can increase their market share.
Key highlights – Value of aggressive anxiety treatment is expected to increase to US$ 26.13 Mn, while that of non-anxiety treatment to US$ 13.85 Mn in 2031.
Key Points Covered in Canine Separation Anxiety Treatment Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Canine Separation Anxiety Treatment and How to Navigate
- Recommendation on Key Winning Strategies
Click Here To get a Sample Report (Including Full TOC, Table & Figures):- https://www.factmr.com/connectus/sample?flag=S&rep_id=1490
Market Overview-
According to Fact.MR – a market research and competitive intelligence provider, in 2020, the global canine separation anxiety treatment market was valued at US$ 21.4 Mn in 2020, and has been expanding at a CAGR of 4.3% over the past years. High prevalence of canine anxiety rising high adoption of canines are primary factors contributing to growth of the market.
On the other hand, the current COVID-19 pandemic has led to a moderate negative impact on the sales of canine separation treatment drugs. As more pet owners have been working from home during this time frame (2020-2021), separation anxiety issues have lessened to a great extent.
Key Points Covered in Canine Separation Anxiety Treatment Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Canine Separation Anxiety Treatment and How to Navigate
- Recommendation on Key Winning Strategies
The Market insights of Canine Separation Anxiety Treatment will improve the revenue impact of businesses in various industries by:
- Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Canine Separation Anxiety Treatment Market
- Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Canine Separation Anxiety Treatment market and offers solutions
- Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
- Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
- Helping leading companies make strategy recalibrations ahead of their competitors and peers
- Offers insights into promising synergies for top players aiming to retain their leadership position in the market & supply side analysis of Canine Separation Anxiety Treatment market .
The latest industry analysis on Canine Separation Anxiety Treatment provides sales outlook in 20+ countries, across key categories. Insights on Canine Separation Anxiety Treatment market drivers, trends, and influencing factors are also included in the study.
We leverage space-age industrial and digitalization tools to provide avant-garde actionable Canine Separation Anxiety Treatment Market insights to our clients. For enhancing readers’ experience, the report starts with a basic overview of the Canine Separation Anxiety Treatment Market and its classification.
Are Limited Number of Approved Drugs Impacting Growth of the Canine Separation Anxiety Treatment Industry?
Considering the global prevalence of canine separation anxiety, lesser number of drugs are approved. The U.S. FDA has approved only two prescription drugs that are used specifically to treat canine separation anxiety. Clomipramine (Elanco Animal Health) and fluoxetine hydrochloride (Reconcile, Pegasus Laboratories, Inc.) are approved for treating the behavioural disorder.
-
By Drug Molecule
- Alprazolam (XanaX) Canine Separation Anxiety Treatment
- Amitriptyline Canine Separation Anxiety Treatment
- Buspirone Canine Separation Anxiety Treatment
- Clomipramine Canine Separation Anxiety Treatment
- Dexmedetomidine Canine Separation Anxiety Treatment
- Diazepam (Valium) Canine Separation Anxiety Treatment
- Fluoxetine Hydrochloride Canine Separation Anxiety Treatment
- Others
-
By Anxiety Type
- Aggressive Canine Separation Anxiety Treatment
- Non-Aggressive Canine Separation Anxiety Treatment
-
By Distribution Channel
- Canine Separation Anxiety Treatment through Veterinary Hospitals
- Canine Separation Anxiety Treatment through Veterinary Clinics
- Canine Separation Anxiety Treatment through Pharmacies & Drug Stores
- Canine Separation Anxiety Treatment through Online Pharmacies
Buy Now for Exclusive Analyst Support :- https://www.factmr.com/checkout/1490
This report gives you access to decisive data such as:
- Demand of Canine Separation Anxiety Treatment Market & Growth drivers
- Factors limiting Canine Separation Anxiety Treatment market growth
- Current key trends of Canine Separation Anxiety Treatment Market
- Market Size of Canine Separation Anxiety Treatment and Canine Separation Anxiety Treatment Market Sales projections for the coming years
Market players involved in canine separation anxiety treatment are engaged in expanding their regional presence through acquisitions, collaborations, expansions, product launches, and strengthening their existing distribution network.
- In August 2019, Zoetis acquired Platinum Performance, a nutrition-focused animal health business, which offers its nutritional products formulas for dogs, cats, and horses.
- In October 2019, Zoetis acquired Phoenix Lab, a leading veterinary reference laboratory, to enhance its offerings in veterinary diagnostic space.
- In November 2016, Pegasus Laboratory (PRN Pharmacal) acquired Veterinary Products Laboratories (VPL) animal health, which focused on providing veterinary products for companion animals.
Key Question answered in the Survey of Canine Separation Anxiety Treatment market Report By Fact.MR :
- Canine Separation Anxiety Treatment Market Company & brand share analysis: Company and brand share analysis on Canine Separation Anxiety Treatment reveals how much market share is captured by Tier 1, Tier 2, and Tier 3 players
- Canine Separation Anxiety Treatment Market Machinery Historical volume analysis: The industry analysis provides data & insights on historical volume sales of Canine Separation Anxiety Treatment Market
- Canine Separation Anxiety Treatment Category & segment level analysis: Fact.MR’s Canine Separation Anxiety Treatment market sales outlook offers category and segment level analysis on lucrative and nascent product types. Market players can use this information to identify sales potential and set sales targets at local, country, and regional level.
- Canine Separation Anxiety Treatment market Consumption by demographics: The market intelligence study provides consumption by demographics analysis so market players can design their product and marketing strategies on the basis of high-value consumers
- Post COVID consumer spending on Canine Separation Anxiety Treatment market: The report includes post COVID consumer spending analysis. This information will help business leads understand the shifts in purchasing power and behavior
- Manufacturing trend analysis: Vital information on how market players are aligning their manufacturing strategies with respect to evolving consumer sentiments
- Canine Separation Anxiety Treatment market Merger and acquisition activity: MR’s analysis also includes merger & acquisition activity analysis. Canine Separation Anxiety Treatment market manufacturers and stakeholders will not only know the recent M&As but also understand its impact on competitive landscape and market share
- Canine Separation Anxiety Treatment Market demand by country: The report forecasts Canine Separation Anxiety Treatment Market demand by country, giving business leaders the insights to know fast-growing, stable, and mature markets
The report also offers key trends of Canine Separation Anxiety Treatment market and an in-depth analysis of how the projected growth factors will shape the Canine Separation Anxiety Treatment market dynamics in the coming years of the forecast period.
Moreover, it also gives meaningful as well as actionable insights on the competitive analysis of Canine Separation Anxiety Treatment Market that are developing the current market scenario and which will be lucrative for the future demand of Canine Separation Anxiety Treatment Market .
Will High Cost of Veterinary Care Hamper Demand for Canine Separation Anxiety Treatment?
Despite the growing trend of pet care insurance, the number of pets covered for treatment is very low. Consequently, pet parents have to bear with majority of the cost of treatment, including routine visits, surgeries, and other health conditions.
One of the primary causes for increase in veterinarian expenses is that medicine technology has progressed. Moreover, every pet, be it a dog or cat, has their own unique personality and independent needs. Also, if a pet owner has dogs two of different breeds, it requires different medical attention. This is yet another factor responsible for rise in veterinary costs.
Also, some medicines are required to be taken by the pet for an extended amount of time or even throughout their life, and this quickly adds up to the overall medication cost.
Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1490
Crucial insights in Canine Separation Anxiety Treatment market research report :
- Underlying macro- and microeconomic factors impacting the Sales of Canine Separation Anxiety Treatment market.
- Basic overview of the Canine Separation Anxiety Treatment, including market definition, classification, and applications.
- Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
- Adoption trend And supply side analysis of Canine Separation Anxiety Treatment across various industries.
- Important regions and countries offering lucrative opportunities to market stakeholders.
Country-wise Analysis
What Makes the U.S. a Large Market for Canine Separation Anxiety Treatment?
The canine separation anxiety treatment industry survey for the U.S. estimates that the market topped US$ 6.4 Mn in 2020. Growth is attributed to high number of dogs suffering from canine separation anxiety in the country.
Canines suffering from separation anxiety are very attached to their owners and get extremely disturbed when left alone. In response to this, they show aggressive behavior.
Approximately 13 million dogs in the U.S. suffer from canine separation anxiety, which has a huge impact on their quality of life and long-term health. Thus, high number of dogs suffering from canine separation anxiety will drive he demand for medications to calm their aggressive behavior, which is anticipated to drive market in the country.
Why is Clomipramine to Most Preferred Drug Used to Treat Canine Separation Anxiety?
Clomipramine is expected to be the most preferred type of drug used to treat canine separation anxiety. Also, Clomipramine is the most effective in reducing separation-related behavior by calming anxiety issues.
Clomipramine, when administered at a dosage of 1mg/kg at a 12-hour interval, increases passive behavior and reduces pacing scratching and whining of dogs in absence of its owner. Also, when the dosage is increased to 2mg/kg every 12 hours, it produces additional improvements and promotes more passive behavior when dogs are left alone.
Owing to these benefits, demand for Clomipramine is growing among veterinarians to treat canine separation anxiety issues, thus capturing the largest share in the market by drug molecule.
How is Canine Separation Anxiety Treatment Demand Outlook Shaping in China?
The market in China is anticipated to reach US$ 6.8 Mn by 2031, and is expected to expand at a CAGR of 7% over the forecast period. High adoption of canines as compared to other pets in China is one of the primary factors creating a positive impact on market growth. According to a Chinese pet industry whitepaper, in 2019, overall, 55 million canines were adopted as compared to 44.1 million cats.
Greater adoption of canine population is expected to drive demand for canine healthcare and medication services, including the treatment for separation anxiety.
Leading Companies Profiled in the Canine Separation Anxiety Treatment Market are:
To provide decision-makers with credible insights on their competitive landscape, the Canine Separation Anxiety Treatment Market industry research report includes detailed competitive landscape analysis.
The competitive landscape analysis for Canine Separation Anxiety Treatment Market includes detailed profiles of Tier 1, Tier 2, and Tier 3 players.
The respective market share of Canine Separation Anxiety Treatment manufacturers is provided so business leaders can understand the market scenario.
What are the Key Opportunities for Stakeholders in Canine Separation Anxiety Treatment?
Overall cost of treating canine separation anxiety is significantly higher with branded drugs, and is anticipated to remain higher, especially when compared with generic or other extra-label/off-label drugs. These higher costs have driven demand of lower cost treatment alternatives. For example, demand for diazepam for canines has seen a gradual decrease over the years.
Also, some of the approved drugs such as Clomipramine have lost their patent, which had led to the development of generic versions. Thus, demand for lower cost alternatives are expected to create lucrative opportunities for players operating in the canine separation anxiety treatment space. Sales of amitriptyline for dogs have been witnessing a decrease over the years. Similarly, demand for amitriptyline for dogs has also been affected.
An assessment on the winning strategies of key Canine Separation Anxiety Treatment Market manufacturers is provided, with recommendation on what works well in Canine Separation Anxiety Treatment Market landscape.
How Big is the Opportunity for Online Veterinary Pharmacies for Canine Separation Anxiety Treatment?
The distribution structure of veterinary drugs is changing as the Internet becomes more widely accessible around the world. The number of online veterinary pharmacies is growing, as pet owners increasingly use the Internet to research disease signs and place orders for over-the-counter (OTC) drugs as well as prescription drugs.
Also, certain compounding pharmacies provide doorstep deliveries of vet medicines after receiving online orders. This trend is most common in the U.S., Europe, and Pacific countries, owing to the availability of online catalogues for prescription drugs.
Moreover, to capitalize on the growth opportunities, venture capital firms are investing in e-Commerce to provide dispensing services to pet owners.
In this regard, Vets First Choice, in July 2017, raised US$ 223 million to introduce its new innovative services and expand its offerings in the European and Asian markets. The Vets First Choice platform enables practitioners to track medication and service compliance as well as connect clients proactively to solve unmet pet care needs.
Additionally, Vets First Choice uses an e-Commerce platform to help veterinarians compete with larger online competitors by facilitating medicine dispensing to pet owners.
More Related Reports By Fact.MR On Healthcare Domain :
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
